Crescita Therapeutics Inc Cash Flow Reinvestment Rate
Crescita Therapeutics Inc cash flow reinvestment rate. Crescita Therapeutics Inc (CTX) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting CA$724.00K (capex CA$724.00K ) from operating cash flow of CA$416.00K. Explore Crescita Therapeutics Inc (CTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Crescita Therapeutics Inc (2019–2025)
Cash flow reinvestment rate of Crescita Therapeutics Inc from 2019 to 2025. Historical reinvestment intensity for Crescita Therapeutics Inc across 5 annual periods. Explore Crescita Therapeutics Inc (CTX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Crescita Therapeutics Inc Cash Flow Reinvestment Rate by Year (2019–2025)
Crescita Therapeutics Inc cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Crescita Therapeutics Inc. For the full cash flow conversion analysis, see CTX operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CA$333.00K | CA$1.07 Million | CA$333.00K | ▼ -73.6% |
| 2024 | 1.18x | CA$3.20 Million | CA$2.73 Million | CA$1.19 Million | ▲ +817.6% |
| 2023 | 0.13x | CA$266.00K | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.02x | CA$118.00K | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.08x | CA$430.00K | CA$5.31 Million | CA$215.00K | — |